Results 51 to 60 of about 50,416 (260)

Future of Statins in Sepsis: A Review on Its Safety and Efficacy

open access: yesArchives of Pharmaceutical Sciences Ain Shams University, 2020
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Statins [Hydroxymethylglutaryl-CoA reductase inhibitors] not only lower cholesterol levels but also have been proposed as adjunctive therapy in sepsis due
Sara Eladwy, Naglaa Bazan
doaj   +1 more source

Modern Management of Asymptomatic Carotid Stenosis: A Meta‐Analysis of CREST‐2, SPACE‐2, and ECST‐2

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Recent randomized trials (CREST‐2, SPACE‐2, and ECST‐2) have compared carotid revascularization (carotid endarterectomy [CEA] or carotid artery stenting [CAS]) plus contemporary medical therapy (CMT) versus CMT alone in asymptomatic carotid stenosis.
Aasim Ali   +14 more
wiley   +1 more source

Statins in Neurological Disorders: Mechanisms and Therapeutic Value

open access: yesThe Scientific World Journal, 2009
Statins are well-tolerated, mainstay drugs in cardiovascular risk management. In addition to their cholesterol-lowering properties, statins also have anti-inflammatory, vasculoprotective, and antioxidant effects.
Allison B. Reiss, Elzbieta Wirkowski
doaj   +1 more source

Life or Death? Autophagy in Anticancer Therapies with Statins and Histone Deacetylase Inhibitors

open access: yes, 2012
Autophagy, which could be either cytoprotective or cytotoxic , is often observed in tumor cells in response to chemotherapy. Understanding the signaling pathways involved in the regulation of autophagy represents a new direction in the development of ...
楊培銘;陳青周   +1 more
core   +1 more source

New insights into the therapeutic potentials of statins in cancer

open access: yesFrontiers in Pharmacology, 2023
The widespread clinical use of statins has contributed to significant reductions of cardiovascular morbidity and mortality. Increasing preclinical and epidemiological evidences have revealed that dyslipidemia is an important risk factor for ...
Chengyu Liu   +6 more
doaj   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley   +1 more source

Safety of statins

open access: yesIndian Journal of Endocrinology and Metabolism, 2013
Statins are an established class of drugs with proven efficacy in cardiovascular risk reduction. The concern over statin safety was first raised with the revelation of myopathy and rhabdomyolysis with the use of now withdrawn cerivastatin.
Debasish Maji   +3 more
doaj   +1 more source

Statins dose-dependently exert a significant chemopreventive effect on colon cancer in patients with chronic obstructive pulmonary disease: A population-based cohort study

open access: yes, 2017
Purpose: We evaluated the chemopreventive effect of statins on colon cancer in patients with chronic obstructive pulmonary disease (COPD) and identified the statin exerting the strongest chemopreventive effect.
Liu, Ju-Chi;Hao, Wen-Rui;Hsu, Yi-Ping;Sung, Li-Chin;Kao, Pai-Feng;Lin, Chao-Feng;Wu, Alexander T. H.;Yuan, Kevin Sheng-Po;Wu, Szu-Yuan
core   +1 more source

Perioperative use of statins in noncardiac surgery [PDF]

open access: yes, 2008
Background: Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) can significantly decrease cardiovascular mortality and morbidity, irrespective of the patients' cholesterol status.
SW Cheng   +5 more
core   +1 more source

Dysregulated Cholesterol Metabolism, Chronic Inflammation, and Disability in Severe Progressive Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Dysregulated lipid metabolism, which can affect remyelination and neural repair, has not been extensively investigated in progressive multiple sclerosis (PMS). The goal was to examine whether dysregulated cholesterol metabolism was associated with disability in PMS. Methods The study sample comprised 53 Severe PMS patients (Expanded
Taylor R. Wicks   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy